As previously reported, Melius Research downgraded Southwest to Sell from Hold with a price target of $19, down from $30. Southwest’s strategy to outgrow their issues is “not working” and there are two paths Southwest can take – either move forward with the current plan or reset by slowing growth – both of which pose downside risk, the analyst tells investors. Melius’ EPS estimates are 55% below the Street in 2024 and 47% below consensus in 2025, the analyst noted.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on LUV:
- Southwest downgraded to Sell from Hold at Melius Research
- Southwest management to meet virtually with Benchmark
- Southwest downgraded to Underperform from Neutral at Exane BNP Paribas
- Southwest signs pact with USA BioEnergy to purchase up to 680M gallons of SAF
- Southwest price target lowered to $18 from $20 at Jefferies